Listonstreetpulse.com announces that a record volume of shares of Arrayit Corporation’s (OTC: ARYC) common stock traded during the third quarter of 2013. During the quarter, a total of 7,824,870 shares of ARYC common stock were bought and sold on the market, which represents around 43% of the company’s current 18,000,000 share float.
The trading volume for the quarter represents a 696% volume increase over the first quarter of 2013 and a 242% increase over the second quarter of 2013. The increase in the trading volume correlates with a 423% increase in ARYC share price in the third quarter of 2013 compared to the second quarter of 2013.
Technical traders generally consider an increase in trading volume as a sign that shares may move higher in the future. ARYC stock price and volume information is available online from OTCmarkets at the following link: http://www.otcmarkets.com/stock/ARYC/quote.
To read more about ARYC and subscribe to a monthly update, CEO interview etc, please click here – http://www.listonstreetpulse.com/tag/ARYC/
About Arrayit Corporation
Arrayit Corporation is a Sunnyvale, California-based company leading and empowering the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development, and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. The company’s innovative products and services help scientists and clinicians explore the human genome as well as the genomes of plants and animals. Arrayit’s products are used by every major research center in the world.
About Liston Street Pulse
Liston Street Pulse is a leading provider of financial research. The company has significant expertise in U.S. listed small cap and micro-cap stocks. Over the years, Liston Street Pulse’s original and unbiased analysis has helped the investor community immensely.
